APA (7th ed.) Citation

Frank, S. (2009). Tetrabenazine as anti-chorea therapy in Huntington Disease: An open-label continuation study. Huntington Study Group/TETRA-HD Investigators. BMC neurology, 9(1), 62. https://doi.org/10.1186/1471-2377-9-62

Chicago Style (17th ed.) Citation

Frank, Samuel. "Tetrabenazine as Anti-chorea Therapy in Huntington Disease: An Open-label Continuation Study. Huntington Study Group/TETRA-HD Investigators." BMC Neurology 9, no. 1 (2009): 62. https://doi.org/10.1186/1471-2377-9-62.

MLA (9th ed.) Citation

Frank, Samuel. "Tetrabenazine as Anti-chorea Therapy in Huntington Disease: An Open-label Continuation Study. Huntington Study Group/TETRA-HD Investigators." BMC Neurology, vol. 9, no. 1, 2009, p. 62, https://doi.org/10.1186/1471-2377-9-62.